Kellanova Q2 adjusted EPS $0.94, down 6.9% YoY; net sales flat; Mars merger on track for year-end 2025

KELLANOVA

2025-Q2 EPS reported $1.72 revenue$6,286,000,000

Reported net sales $3.20B vs $3.19B (+0.3%); organic net sales +0.3%.
Adjusted diluted EPS $0.94 vs $1.01 (-6.9%); reported EPS $0.85 vs $1.00 (-15%).
Mars transaction at $83.50/share approved by shareowners; expected close end of 2025.
No forward guidance provided due to pending merger.
Emerging markets growth led by noodles in Africa; category softness persists.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.